Literature DB >> 18039634

Role of macrophages in host defense against aspergillosis and strategies for immune augmentation.

Brahm H Segal1.   

Abstract

Invasive aspergillosis is a major cause of morbidity and mortality in highly immunocompromised patients with cancer. Alveolar macrophages ingest inhaled conidia (spores). Through pathogen recognition receptors that ligate fungal cell wall motifs, macrophages are able to coordinate the inflammatory response to Aspergillus species. Macrophages and dendritic cells play an important role in regulating the balance between the proinflammatory and anti-inflammatory cytokine responses that are required for recruitment and activation of neutrophils, and in augmenting or attenuating cellular immunity. Macrophages are therefore a target for immune augmentation strategies that include administration of cytokines, colony-stimulating factors, and pathogen recognition receptor ligands.

Entities:  

Mesh:

Year:  2007        PMID: 18039634     DOI: 10.1634/theoncologist.12-S2-7

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  28 in total

Review 1.  Regulation of T cell immunity by cellular metabolism.

Authors:  Zhilin Hu; Qiang Zou; Bing Su
Journal:  Front Med       Date:  2018-08-16       Impact factor: 4.592

Review 2.  Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection.

Authors:  I Mirkov; S Stosic-Grujicic; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

3.  Scedosporium apiospermum brain abscesses in an immunocompetent man with silicosis.

Authors:  Heather L Wilson; Karina J Kennedy
Journal:  Med Mycol Case Rep       Date:  2013-03-01

Review 4.  Allergic Inflammation in Aspergillus fumigatus-Induced Fungal Asthma.

Authors:  Sumit Ghosh; Scott A Hoselton; Jane M Schuh
Journal:  Curr Allergy Asthma Rep       Date:  2015-10       Impact factor: 4.806

5.  Aspergillus fumigatus allergen expression is coordinately regulated in response to hydrogen peroxide and cyclic AMP.

Authors:  Marcin G Fraczek; Rifat Rashid; Marian Denson; David W Denning; Paul Bowyer
Journal:  Clin Mol Allergy       Date:  2010-11-03

6.  Concurrent silicosis and pulmonary mycosis at death.

Authors:  Yulia Iossifova; Rachel Bailey; John Wood; Kathleen Kreiss
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

7.  In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis.

Authors:  Oumaïma Ibrahim-Granet; Grégory Jouvion; Tobias M Hohl; Sabrina Droin-Bergère; François Philippart; Oh Yoen Kim; Minou Adib-Conquy; Reto Schwendener; Jean-Marc Cavaillon; Matthias Brock
Journal:  BMC Microbiol       Date:  2010-04-08       Impact factor: 3.605

8.  Therapy of murine pulmonary aspergillosis with antibody-alliinase conjugates and alliin.

Authors:  Elena Appel; Alexandra Vallon-Eberhard; Aharon Rabinkov; Ori Brenner; Irina Shin; Keren Sasson; Yona Shadkchan; Nir Osherov; Steffen Jung; David Mirelman
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

Review 9.  Review: Is lung inflammation associated with microbes and microbial toxins in cigarette tobacco smoke?

Authors:  John L Pauly; Lauren A Smith; Michael H Rickert; Alan Hutson; Geraldine M Paszkiewicz
Journal:  Immunol Res       Date:  2010-03       Impact factor: 2.829

10.  Differential expression of Toll-like receptors on human alveolar macrophages and autologous peripheral monocytes.

Authors:  Esmeralda Juarez; Carlos Nuñez; Eduardo Sada; Jerrold J Ellner; Stephan K Schwander; Martha Torres
Journal:  Respir Res       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.